Study identifier:D5252C00002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Randomized, Double-Blind, Active-Controlled, Parallel Group, Stratified, Multicenter, 12-Week Study to Evaluate the Safety and Efficacy after Multiple Dosing of Investigational Budesonide HFA Metered Dose Inhalers Compared with Conventional Budesonide CFC Metered Dose Inhalers (Pulmicort) in Patients with Asthma.
asthma
Phase 3
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|